Robert S. Wallis
Department of Medicine
University of Medicine and Dentistry of New Jersey-New Jersey Medical School
Newark
NJ 07103
USA
Name/email consistency: high
- A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis. Wallis, R.S., Kyambadde, P., Johnson, J.L., Horter, L., Kittle, R., Pohle, M., Ducar, C., Millard, M., Mayanja-Kizza, H., Whalen, C., Okwera, A. AIDS (2004)
- Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Wallis, R.S., Broder, M.S., Wong, J.Y., Hanson, M.E., Beenhouwer, D.O. Clin. Infect. Dis. (2004)
- Whole blood bactericidal activity during treatment of pulmonary tuberculosis. Wallis, R.S., Vinhas, S.A., Johnson, J.L., Ribeiro, F.C., Palaci, M., Peres, R.L., Sá, R.T., Dietze, R., Chiunda, A., Eisenach, K., Ellner, J.J. J. Infect. Dis. (2003)
- A study of the immunology, virology, and safety of prednisone in HIV-1-infected subjects with CD4 cell counts of 200 to 700 mm(-3). Wallis, R.S., Kalayjian, R., Jacobson, J.M., Fox, L., Purdue, L., Shikuma, C.M., Arakaki, R., Snyder, S., Coombs, R.W., Bosch, R.J., Spritzler, J., Chernoff, M., Aga, E., Myers, L., Schock, B., Lederman, M.M. J. Acquir. Immune Defic. Syndr. (2003)